Narrowing the spectrum: development of a UK paediatric antimicrobial prescribing summary
Arch Dis Child
.
2022 Jul;107(7):698-699.
doi: 10.1136/archdischild-2022-323858.
Epub 2022 Feb 21.
Authors
Annalie Shears
1
,
Alicia Demirjian
2
3
4
,
Orlagh McGarrity
5
,
Stefania Vergnano
6
,
Sanjay Valabh Patel
7
,
Paddy McMaster
8
Affiliations
1
Paediatrics, Manchester University NHS Foundation Trust, Manchester, UK annalieshears@gmail.com.
2
Paediatric Infectious Diseases and Immunology, Evelina London Children's Hospital, London, UK.
3
Health Associated Infections and Antimicrobial Resistance, UK Health Security Agency, London, UK.
4
Faculty of Life Sciences and Medicine, Kings College London, London, UK.
5
Pharmacy, Evelina London Children's Hospital, London, UK.
6
Paediatric Infectious Diseases and Immunology, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK.
7
Paediatric Infectious Diseases and Immunology, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
8
Paediatric Infectious Diseases, Manchester University NHS Foundation Trust, Manchester, UK.
PMID:
35190382
DOI:
10.1136/archdischild-2022-323858
No abstract available
Keywords:
infectious disease medicine; microbiology; paediatrics; pharmacology.
Publication types
Letter
MeSH terms
Anti-Bacterial Agents* / therapeutic use
Child
Drug Prescriptions
Humans
Inappropriate Prescribing*
United Kingdom
Substances
Anti-Bacterial Agents